NEW:

Cybersecurity Learning Bundle
Menu +

Resource Details

Menu

The Rising Incidence of Maternal Syphilis and What We Need to Do About It

Year Developed: 2024

Resource Type: Archived Webinar.

Primary Audience: C-Suite (CEOs, CFOs, CIO, COOs, CMOs, etc.) Clinicians
Secondary Audience: PCAs

Language(s): Chinese

Developed by: Renaye James Healthcare Advisors (RJHA) (See other resources developed by this organization).

Resource Summary: This webinar discussed how to evaluate individuals at higher risk for becoming infected with syphilis and reviewed the screening tests, diagnosis, and treatment for pregnant individuals to minimize the risk of the fetus acquiring congenital syphilis. This webinar discussed direct patient care strategies to mitigate complications in the postpartum period. This training was in condition with the National Coalition of STD Directors.

Resource Details: Syphilis is a sexually transmitted infectious disease that has experienced a 676 percent increase in prevalence in females of reproductive age from 2012 to 2021 in the United States. The organism that causes syphilis is Treponema pallidum and can cross the placenta to infect a fetus, causing congenital syphilis. Although pregnant individuals from vulnerable populations are more likely to become infected, syphilis is not a disease exclusive to vulnerable communities. Understanding this public health issue, the webinar speakers apply their knowledge of this trend and how important it is to address in current times.

Resource Topic: Clinical Issues, Special and Vulnerable Populations

Keywords: Access to Care, Care Coordination, Chronic Diseases and Care, Communication, Transparency, and Outreach, Education of - Staff (e.g., Competency-Based), Health Risk and Behavior, Infectious Diseases, Integrated Care, Sexually Transmitted Infections (STIs), Team-Based Care.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.